红细胞输注无效研究专家共识

红细胞输注无效专家共识编写组

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1189 -1203.

PDF (2993KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1189 -1203. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.09.006
专家共识

红细胞输注无效研究专家共识

作者信息 +

Expert consensus on research of red blood cell transfusion refractoriness

Author information +
文章历史 +
PDF (3064K)

摘要

目前临床上红细胞输注无效(RTR)发生率较高。 RTR 的发生不仅影响患者治疗效果、增加患者的经济负担,还造成血液资源的浪费。 目前临床上存在诊断标准不一、漏检等诸多问题。 本共识旨在统一临床诊疗规范,提出 RTR 诊断及预防策略,减少输血反应与血液资源浪费,改善患者长期预后,为全国医疗机构 RTR 全流程管理提供循证指导。

Abstract

The incidence of red blood cell transfusion refractoriness (RTR) remains high in clinical practice. The occurrence of RTR not only impairs therapeutic efficacy and increases patients’ financial burden, but also leads to the waste of blood resources. Currently, clinical practice is plagued by inconsistent diagnostic criteria and missed detection. This consensus aims to standardize clinical diagnosis and treatment protocols, propose diagnostic and preventive strategies for RTR, reduce transfusion reactions and blood waste, improve patients’ long-term prognosis, and provide evidence-based guidance for the full-cycle management of RTR in medical institutions across the country.

关键词

红细胞输注无效 / 诊断 / 预防

Key words

red blood cell transfusion refractoriness / diagnosis / prevention

引用本文

引用格式 ▾
红细胞输注无效专家共识编写组. 红细胞输注无效研究专家共识[J]. 中国输血杂志, 2026, 39(9): 1189-1203 DOI:10.13303/j.cjbt.issn.1004-549x.2026.09.006

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

GOEL R, TOBIAN A A R, SHAZ B H. Noninfectious transfusion-associated adverse events and their mitigation strategies[J].Blood, 2019, 133(17):1831-1839.

[2]

MUELLER M M, VAN REMOORTEL H, MEYBOHM P, et al. Patient blood management: recommendations from the 2018 frankfurt consensus conference[J].JAMA, 2019, 321(10):983-997.

[3]

吕运来,孙先玲,兰炯采,等. 临床输血 500 例疗效调查分析[J].中国输血杂志,2006(6):488-489.

[4]

LV Y L, SUN X L, LAN J C, et al. Investigation and analysis of therapeutic efficacy of clinical blood transfusion in 500 cases[J].Chin J Blood Transfusion, 2006(6): 488-489.

[5]

曹廷卉,王广杰. 红细胞输注的疗效观察与输注无效的探讨[J].中国输血杂志,2015, 28(10):1241-1243.

[6]

CAO T H, WANG G J. Observation of red blood cell transfusion efficiency and analysis of unsuccessful transfusion[J].Chin J Blood Transfusion, 2015, 28(10): 1241-1243.

[7]

李志静. 红细胞输注无效的原因与安全输血[J].中国输血杂志,2017,30(4):381-383.

[8]

LI Z J. Causes and therapeutic countermeasures for red blood cell infusion failure[J].Chin J Blood Transfusion, 2017, 30(4):381-383.

[9]

DESAI N, SCHOFIELD N, RICHARDS T. Perioperative patient blood management to improve outcomes[J].Anesthesia & Analgesia,2018,127(5):1211-1220.

[10]

杨成民,刘进,赵桐茂. 中华输血学[M]. 2 版.北京:人民卫生出版社,2021:520.

[11]

YANG C M, LIU J, ZHAO T M. Chinese Transfusion Medicine[M]. 2nd ed. Beijing:People's Medical Publishing House,2021.

[12]

ELIZALDE J I, CLEMENTE J, MARIN J L, et al. Early changes in hemoglobin and hematocrit levels after packed red cell transfusion in patients with acute anemia[J].Transfusion,1997,37(6):573-576.

[13]

HOD E A, SPITALNIK S L. Harmful effects of transfusion of older stored red blood cells:iron and inflammation[J].Transfusion,2011,51(4):881-885.

[14]

CARSON J L, GROSSMAN B J, KLEINMAN S, et al. Red blood cell transfusion:a clinical practice guideline from the AABB[J].Ann Intern Med,2012,157(1):49-58.

[15]

曹微微,黄琬婷,李碧娟,等. 4148 例输血患者红细胞输注无效的调查分析[J].中国现代医学杂志,2018, 28(23):77-82.

[16]

CAO W W, HUANG W T, LI B J, et al. Investigation and analysis of invalid red blood cell transfusion in 4,148 cases of blood cell transfusion[J].China Journal of Modern Medicine, 2018, 28(23):77-82.

[17]

WANG Q, SU X, HE Y, et al. CD11c participates in triggering acute graft-versus-host disease during bone marrow transplantation[J]. Immunology, 2021, 164 (1):148-160.

[18]

王伟,李娜,袁君,等. 红细胞输注无效原因的分析[J].临床输血与检验,2020,22(6):649-652.

[19]

WANG W, LI N, YUAN J, et al. Research progresses on the causes of ineffective red blood cells transfusion[J].J Clin Transfus Lab Med, 2020, 22(6):649-652.

[20]

VAMVAKAS E C, BLAJCHMAN M A. Transfusion-related immunomodulation(TRIM):an update[J].Blood Rev,2007,21(6):327-348.

[21]

SEICEAN A, SEICEAN S, ALAN N, et al. Preoperative anemia and perioperative outcomes in patients who undergo elective spine surgery[J].Spine (Phila Pa 1976), 2013,38(15):1331-1341.

[22]

HEBERT P C, WELLS G, BLAJCHMAN M A, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group[J].N Engl J Med, 1999, 340 (6):409-417.

[23]

BORDIN J O, HEDDLE N M, BLAJCHMAN M A. Biologic effects of leukocytes present in transfused cellular blood products[J].Blood,1994,84(6):1703-1721.

[24]

KARROWNI W, VORA A N, DAI D, et al. Blood transfusion and the risk of acute kidney injury among patients with acute coronary syndrome undergoing percutaneous coronary intervention[J].Circ Cardiovasc Interv, 2016,9(9):e003279.

[25]

COATES T D. Management of iron overload:lessons from transfusion-dependent hemoglobinopathies[J].Blood, 2025,145(4):359-371.

[26]

HOD E A, ZHANG N, SOKOL S A, et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation[J].Blood,2010,115(21):4284-4292.

[27]

MUSZYNSKI J A, SPINELLA P C, CHOLETTE J M, et al. Transfusion-related immunomodulation:review of the literature and implications for pediatric critical illness[J].Transfusion,2017,57(1):195-206.

[28]

LIN J, WANG C, LIU J, et al. Prevalence and intervention of preoperative anemia in Chinese adults:A retrospective cross-sectional study based on national preoperative anemia database[J].E Clinical Medicine,2021, 36:100894.

[29]

FLEGEL W A. Pathogenesis and mechanisms of antibody-mediated hemolysis[J]. Transfusion, 2015, 55 (Suppl2):S47-S58.

[30]

BRODSKY R A. Warm autoimmune hemolytic anemia[J].N Engl J Med,2019,381(7):647-654.

[31]

FU Z, HAO X, GAO W, et al. Research progress in RBC alloimmunization[J].Front Immunol, 2025, 16: 1677581.

[32]

IBA T, HELMS J, CONNORS J M, et al. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation[J].J Intensive Care,2023,11(1):24-33.

[33]

BELIZAIRE R, MACK J, KADAUKE S, et al. Red blood cell alloantibodies are associated with increased alloimmunization against human leukocyte antigens[J].Transfusion,2019,59(7):2256-2263.

[34]

WEISS G, GANZ T, GOODNOUGH L T. Anemia of inflammation[J].Blood,2019, 133(1):40-50.

[35]

FRAENKEL P G. Anemia of inflammation:a review[J].Med Clin North Am,2017, 101(2):285-296.

[36]

EFFENBERGER-NEIDNICHT K, HARTMANN M. Mechanisms of Hemolysis During Sepsis[J].Inflammation, 2018,41(5):1569-1581.

[37]

MAQUET J, LAFAURIE M, MICHEL M, et al. Drug-induced immune hemolytic anemia:detection of new signals and risk assessment in a nationwide cohort study[J].Blood Adv,2024,8(3):817-826.

[38]

KAUFMAN R M, DINH A, COHN C S, et al. Electronic patient identification for sample labeling reduces wrong blood in tube errors[J].Transfusion,2019,59(3):972-980.

[39]

SAHIN I, REAGAN J L, NIROULA R, et al. Refractoriness to red blood cell transfusion therapy due to hypersplenism[J].Transfusion,2018,58(11):2513-2516.

[40]

PUTTER J S, SEGHATCHIAN J. Cumulative erythrocyte damage in blood storage and relevance to massive transfusions: selective insights into serial morphological and biochemical findings[J].Blood Transfus,2017,15 (4):348-356.

[41]

NEMKOV T, KEY A, STEPHENSON D, et al. Genetic regulation of carnitine metabolism controls lipid damage repair and aging RBC hemolysis in vivo and in vitro[J].Blood,2024,143(24):2517-2533.

[42]

HENDRICKSON J E, MENDOZA H, ROSS R, et al. Investigation of increased platelet alloimmunization screening in the era of pathogen-reduced platelets treated with psoralen/ UV light[J].Transfusion,2020,60(3): 650-651.

[43]

MURPHY G J, REEVES B C, ROGERS C A, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery[J].Circulation,2007,116(22):2544-2552.

[44]

OMAR H R, MIRSAEIDI M, SOCIAS S, et al. Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support[J].PLoS One,2015,10(4):e0124034.

[45]

GOONEWARDENE M, SHEHATA M, HAMAD A. Anaemia in pregnancy[J].Best Pract Res Clin Obstet Gynaecol,2012,26(1):3-24.

[46]

JAMES A H. Iron deficiency anemia in pregnancy[J].Obstet Gynecol,2021, 138(4):663-674.

[47]

ROUSSEL C, MOREL A, DUSSIOT M, et al. Rapid clearance of storage-induced microerythrocytes alters transfusion recovery[J].Blood,2021,137(17):2285-2298.

[48]

郑婷婷,施顺秋,张瑛,等. 贫血患者红细胞输注疗效的影响因素分析[J].临床血液学杂志,2020,33(4): 275-277.

[49]

ZHENG T T, SHI S Q, ZHANG Y, et al. Analysis of the factors influencing the therapeutic effect of red blood cell transfusion in anemia patients[J].J Clin Hematol, 2020, 33(4):275-277.

[50]

CHAPUY C I, NICHOLSON R T, AGUAD M D, et al. Resolving the daratumumab interference with blood compatibility testing[J].Transfusion, 2015, 55 (6Pt2): 1545-1554.

[51]

戴小波,任燕歌,曾朱君,等. 直接抗球蛋白试验阳性非自身免疫性溶血性贫血受血者的临床特征和输血对策[J].中国输血杂志,2013,26(6):555-557.

[52]

DAI X B, REN Y G, ZENG Z J, et al. Clinical characteristics and transfusion strategies for recipients with positive direct antiglobulin test and non-autoimmune hemolytic anemia[J].Chin J Blood Transfus, 2013, 26(6): 555-557.

[53]

叶晓芳,黄榕,张玲. 非自身免疫性溶血性贫血患者直接抗人球蛋白试验阳性对临床输血效果的影响[J].实用检验医师杂志,2023,15(3):238-241.

[54]

YE X F, HUANG R, ZHANG L. Impact of direct antiglobulin test positive results on blood transfusion efficacy in non-autoimmunehemolytic anemia patients[J]. J Pract Lab Physicians, 2023, 15(3):238-241.

[55]

中华预防医学会血液安全专业委员会红细胞血型意外抗体筛查专家共识编写组. 红细胞血型意外抗体筛查专家共识[J].中国输血杂志,2024,37 (4):369-376.

[56]

Expert Consenus Writing Group of Unexpected Red Blood Cell Antibody Screening, the Blood Safety Professional Committee, Chinese Preventive Medicine Association. Expert consensus on screening for unexpected red blood cell antibodies[J].Chin J Blood Transfus, 2024, 37 (4):369-376.

[57]

ZHENG C, LI S, MUELLER J, et al. Evidence for alcohol-mediated hemolysis and erythrophagocytosis[J]. Redox Biol,2025,85:103742.

[58]

ROCKEY D C. Occult gastrointestinal bleeding[J].Gastroenterol Clin North Am,2005,34(4):699-718.

[59]

COOPER N, MORRISON M A, VLADESCU C, et al. Identification of occult cerebral microbleeds in adults with immune thrombocytopenia[J].Blood, 2020, 136 (25):2875-2880.

[60]

REPCZYNSKA A, CIASTEK B, HAUS O. New insights into the fanconi anemia pathogenesis:a crosstalk between inflammation and oxidative stress[J].Int J Mol Sci, 2024,25(21):11619-11635.

[61]

BYRNE R A, ROSSELLO X, COUGHLAN J J, et al. 2023 ESC guidelines for the management of acute coronary syndromes[J].Eur Heart J, 2023,44(38):3720-3826.

[62]

BATEMAN R M, SHARPE M D, JAGGER J E, et al. 36th international symposium on intensive care and emergency medicine: brussels, belgium. 15-18 March 2016[J].Crit Care, 2016, 20(Suppl2):94.

[63]

REHN M, CHEW M S, OLKKOLA K T, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock in adults 2021-endorsement by the Scandinavian society of anaesthesiology and intensive care medicine[J]. Acta Anaesthesiol Scand, 2022,66(5):634-635.

[64]

GRASSELLI G, CALFEE C S, CAMPOROTA L, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies[J].Intensive Care Med,2023,49(7):727-759.

[65]

陈典,隆寰宇,张丛溪,等. 2025 年 GOLD 慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J].中国全科医学,2025,28(16):1937-1949.

[66]

CHEN D, LONG H Y, ZHANG C X, et al. Interpretation of global strategy for the diagnosis, treatment, management and prevention of chronic obstructive pulmonary disease 2026 report[J].Chin Gen Pract, 2025, 28 (16):1937-1949.

[67]

高峰. 急性缺血性脑卒中血管内治疗中国专家共识[J].中国脑血管病杂志,2014, 11(10):556-560.

[68]

GAO F. Chinese expert consensus on endovascular treatment of acute ischemic stroke[J].Chin J Cerebrovasc Dis, 2014, 11(10):556-560.

[69]

中国卒中学会,中国卒中学会神经介入分会,中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗影像评估中国专家共识[J].中国卒中杂志,2017, 12(11):1041-1056.

[70]

Chinese Stroke Association, Neurointervention Branch Of Chinese Stroke Association, Intervention Group Of Stroke Prevention And Control Professional Committee Of Chinese Preventive Medicine Association. Chinese expert consensus on imaging evaluation for endovascular treatment of acute ischemic stroke[J].Chin J Stroke, 2017, 12(11):1041-1056.

[71]

ALBERS G W, MARKS M P, KEMP S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J].N Engl J Med,2018,378(8):708-718.

[72]

HEIDENREICH P A, BOZKURT B, AGUILAR D, et al. 2022 AHA/ ACC/ HFSA guideline for the management of heart failure:a report of the american college of cardiology/ american heart association joint committee on clinical practice guidelines[J].J Am Coll Cardiol, 2022,79(17):e263-e421.

[73]

PRABHAKARAN S, GONZALEZ N R, ZACHRISON K S, et al. 2026 guideline for the early management of patients with acute ischemic stroke:a guideline from the american heart association/ american stroke association[J].Stroke,2026,57(8):e316-e436.

[74]

国家老年疾病临床医学研究中心《感染诱发的老年多器官功能障碍综合征诊治中国专家共识》撰写组, 边素艳, 曹丰, 等. 感染诱发的老年多器官功能障碍综合征诊治中国专家共识[J].中华老年多器官疾病杂志,2018,17(1):3-15.

[75]

National Clinical Research Center For Geriatric Diseases,the Writing Team of Chinese Expert Consensus on Diagnosis and Treatment of Multiple Organ Dysfunction Syndrome Induced byInfection in the Elderly, BIAN S Y, CAO F, et al. Chinese expert consensus on diagnosis and treatment of multiple organ dysfunction syndrome induced by infection in theelderly[J].Chin J Mult Organ Dis Elderly, 2018, 17(1):3-15.

[76]

INCE C, BOERMA E C, CECCONI M, et al. Second consensus on the assessment of sublingual microcirculation in critically ill patients:results from a task force of the European Society of Intensive Care Medicine[J].Intensive Care Med,2018, 44(3):281-299.

[77]

GERHARD-HERMAN M D, GORNIK H L, BARRETT C, et al. 2016 AHA/ ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the american college of cardiology/ american heart association task force on clinical practice guidelines[J].J Am Coll Cardiol, 2017,69 (11):1465-1508.

[78]

ROUBINIAN N H, PLIMIER C, WOO J P, et al. Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion[J].Blood,2019,134(13):1003-1013.

[79]

中华医学会血液学分会红细胞疾病学组. 静脉铁剂应用中国专家共识(2019 年版)[J].中华血液学杂志, 2019,40(5):358-362.

[80]

Red Blood Cell Diseases (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association. Chinese expert consensus on the application of intravenous iron (2019)[J].Chin J Hematol, 2019, 40(5):358-362.

[81]

MCDONAGH T A, METRA M, ADAMO M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J].Eur Heart J, 2021, 42 (36):3599-3726.

[82]

SONG S N, TOMOSUGI N, KAWABATA H, et al. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease[J].Blood, 2010, 116 (18): 3627-3634.

[83]

CERVANTES F, ROSS D M, RADINOFF A, et al. Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia:the realise phase 2 study[J].Leukemia, 2021, 35 (12):3455-3465.

[84]

British Committee For Standards In Haematology, MILKINS C, BERRYMAN J, et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology[J].Transfus Med, 2013,23(1):3-35.

[85]

HILL Q A, STAMPS R, MASSEY E, et al. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia[J].Br J Haematol, 2017,177(2):208-220.

[86]

MAYER B, BARTOLMAS T, YUREK S, et al. Variability of findings in drug-induced immune haemolytic anaemia:experience over 20 years in a single centre[J].Transfus Med Hemother,2015,42(5):333-339.

[87]

KORMOCZI G F, SAEMANN M D, BUCHTA C, et al. Influence of clinical factors on the haemolysis marker haptoglobin[J].Eur J Clin Invest,2006,36(3):202-209.

[88]

SOUTAR R, MCSPORRAN W, TOMLINSON T, et al. Guideline on the investigation and management of acute transfusion reactions[J].Br J Haematol,2023,201(5): 832-844.

[89]

TONG T N, BLACQUIERE M, SAKAC D, et al. The utility of a monocyte monolayer assay in the assessment of intravenous immunoglobulin-associated hemolysis[J]. Transfusion,2020,60(12):3010-3018.

[90]

ARNDT P A, GARRATTY G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies[J].Transfusion,2004,44(9):1273-1281.

[91]

HORTH R Z, JONES J M, KIM J J, et al. Fatal sepsis associated with bacterial contamination of platelets -Utah and California, august 2017[J].MMWR Morb Mortal Wkly Rep,2018,67(25):718-722.

[92]

FENWICK A J, GEHRIE E A, MARSHALL C E, et al. Secondary bacterial culture of platelets to mitigate transfusion-associated sepsis:A 3-year analysis at a large academic institution[J].Transfusion,2020,60(9):2021-2028.

[93]

D'ALESSANDRO A, YOSHIDA T, NESTHEIDE S, et al. Hypoxic storage of red blood cells improves metabolism and post-transfusion recovery[J]. Transfusion, 2020, 60(4):786-798.

[94]

QAZI M A, RIZZATTI F, PIKNOVA B, et al. Effect of storage levels of nitric oxide derivatives in blood components[J].F1000Res,2012,1:35-50.

[95]

LEI C, YU B, SHAHID M, et al. Inhaled nitric oxide attenuates the adverse effects of transfusing stored syngeneic erythrocytes in mice with endothelial dysfunction after hemorrhagic shock[J].Anesthesiology, 2012, 117 (6):1190-1202.

[96]

桂林,黄远帅,李代渝. 一氧化氮对库存悬浮红细胞变形性的影响[J].现代预防医学, 2015,42(16):3001-3003.

[97]

GUI L, HUANG Y S, LI D Y. The influence of nitric oxide on deformability of red blood cellsuspension stocks[J].Mod Prev Med, 2015, 42(16):3001-3003.

[98]

中华医学会急诊医学分会, 北京医学会急诊医学分会, 北京医师协会急救医学专科医师分会,等. 吸入一氧化氮治疗在急危重症中的临床应用专家共识[J].中华急诊医学杂志, 2024,33(7):907-920.

[99]

Emergency Medicine Branch Of Chinese Medical Association, Emergency Medicine Branch Of Beijing Medical Association, Emergency Medicine Specialist Branch Of Beijing Medical Doctor Association, et al. Expert consensus on clinical application of inhaled nitric oxide therapy in critical illness[J].Chin J Emerg Med, 2024, 33 (7):907-920.

[100]

中华人民共和国国家卫生健康委员会. 内科输血: WS/ T 622-2018[S].北京:中国标准出版社,2018: 1-7.

[101]

National Health Commission Of The People'S Republic Of China. Internal medicine blood transfusion: WS/ T 622-2018[S]. Beijing: Standards Press of China, 2018:1-7.

[102]

中华人民共和国国家卫生健康委员会. 儿科输血指南:WS/ T795-2022[S].北京: 中国标准出版社, 2022:1-17.

[103]

National Health Commission Of The People'S Republic Of China. Guidelines for pediatric blood transfusion: WS/ T 795-2022[S]. Beijing:Standards Press of China,2022:1-17.

[104]

中华人民共和国国家卫生健康委员会. 围手术期患者血液管理指南:WS/ T796-2022[S]. 北京:中国标准出版社,2022:1-9.

[105]

National Health Commission Of The People'S Republic Of China. Guidelines for perioperative patient blood management:WS/ T 796-2022[S]. Beijing:Standards Press of China,2022:1-9.

[106]

雷航,王学锋,程晓文,等. ABO 血型变异的分子基础研究[J].中国输血杂志,2024, 37(4):385-391.

[107]

LEI H, WANG X F, CHENG X W, et al. Molecular mechanism of ABO blood group variation[J].Chin J Blood Transfusion, 2024, 37(4):385-391.

[108]

WANG Z, JIN S, ZHENG J, et al. Prevalence and distribution of serological characteristics of weak ABO subgroups in the Chinese population[J].Hematol Transfus Cell Ther,2024,46(Suppl5):S115-S121.

[109]

刘旭映,黄伯泉,廖芬芳,等. 2021-2022 年广州地区献血人群 ABO 血型筛查结果分析[J].中国输血杂志,2024,37(4):439-443.

[110]

LIU X Y, HUANG B Q, LIAO F F, et al. ABO blood group screening results among blood donors in Guangzhou from 2021 to 2022[J].Chin J Blood Transfus, 2024, 37 (4):439-443.

[111]

王文,李勇,张学友,等. 提高红细胞意外抗体检出率解决策略初探[J].标记免疫分析与临床,2022,29 (10):1737-1740.

[112]

WANG W, LI Y, ZHANG X Y, et al. A preliminary study of the strategies to improve the screening rate of irregular antibody[J].Labeled Immunoass Clin Med, 2022, 29(10):1737-1740.

[113]

WEISBACH V, KOHNHAUSER T, ZIMMERMANN R, et al. Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies[J].Transfus Med,2006,16(4):276-284.

[114]

马曙轩,刘景汉,欧阳锡林,等. 唯酶红细胞抗体的血型血清学特性的研究[J].中国实验血液学杂志, 2003,11(5):527-529.

[115]

MA S X, LIU J H, OUYANG X L, et al. Studies on the blood group serologic characters of enzyme-only red cell antibody[J].J Exp Hematol, 2003,11 (5):527-529.

[116]

谭金哲,金明艳,陈文珠,等. 唯酶抗体致溶血性输血反应原因追踪及文献回顾-附 1 例报告[J].中国输血杂志,2020,33(6):597-600.

[117]

TAN J Z, JIN M Y, CHEN W Z, et al. Trace the cause of hemolytic blood transfusion induced by enzyme-only antibodies and review the literature[J].Chin J Blood Transfusion, 2020, 33(6):597-600.

[118]

红细胞意外抗体筛查与鉴定抗原谱构成中国专家共识起草编写组. 红细胞意外抗体筛查与鉴定抗原谱构成中国专家共识[J].临床输血与检验,2024,26(2): 156-163.

[119]

Expert Consensus Drafting Group of Composition of Antigen Spectrum of Red Blood Cells Unexpected Antibodies Screening, Identification Reagents. Chinese expert consensus on composition of antigen spectrum of red blood cells unexpected antibodies screening and identification reagents[J].J Clin Transfus Lab Med, 2024, 26(2): 156-163.

[120]

GARRATTY G. Immune hemolytic anemia associated with drug therapy[J].Blood Rev,2010,24(4-5):143-150.

[121]

LI Y, LI C, ZHANG L, et al. Long-term storage protocol of reagent red blood cells treated with 0. 01M dithiothreitol (DTT) for pre-transfusion testing of patients receiving anti-CD38 therapy, daratumumab[J].Hematology,2023,28(1):2186037.

[122]

竺青,陈富强,魏蕾,等. 直接抗球蛋白试验阳性患者红细胞输注效果的影响因素分析[J].实用临床医药杂志,2021,25(15):65-68.

[123]

ZHU Q, CHEN F Q, WEI L, et al. Analysis in influencing factors of red blood cell transfusioneffect in patients with positive direct antiglobulin test[J].J Clin Med Pract, 2021, 25(15):65-68.

[124]

曾群娟,康怀应,向东,等. 热放散和酸放散对 IgG 抗-M 和抗-Ku 放散效率比较[J].中国输血杂志,2025, 38(7):964-968.

[125]

ZENG Q J, KANG H Y, XIANG D, et al. Comparison of the efficacy of heat and acid elution methods for IgG anti-M and anti-Ku[J].Chin J Blood Transfusion, 2025, 38(7):964-968.

[126]

中华医学会血液学分会红细胞疾病学组. 红细胞寿命测定在血液系统疾病中的临床应用中国专家共识[J].中华医学杂志,2019,99(30):2321-2324.

[127]

Red Blood Cell Diseases (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association.Chinese expert consensus on clinical application of red blood cell lifespan measurement in hematological diseases[J].Natl Med J China, 2019, 99(30):2321-2324.

[128]

TONG T N, BRANCH D R. Use of a monocyte monolayer assay to evaluate fcgamma receptor-mediated phagocytosis[J].J Vis Exp, 2017,119:55039-55045.

[129]

PETZ L D. Bystander immune cytolysis[J].Transfus Med Rev,2006,20(2):110-140.

[130]

MOTA M, BLEY C, ARAVECHIA M G, et al. Autoantibody formation after alloimmunization inducing bystander immune hemolysis[J]. Immunohematology, 2009, 25(1):9-12.

[131]

陈冠伊,查占山,欧阳锡林,等. 术前深度单采自体红细胞和/ 或血小板储血技术应用中国专家共识[J].临床输血与检验,2024,26(2):145-155.

[132]

CHEN G Y, ZHA Z S, OUYANG X L, et al. Chinese expert consensus on preoperative advanced autologous apheresis[J].J Clin Transfus Lab Med, 2024, 26(2): 145-155.

[133]

HOBSON-PETERS J, AMARILLA A A, RUSTANTI L, et al. Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light[J].Transfusion,2023,63(2):288-293.

[134]

李小飞,马春娅,蔡晓红,等. 红细胞血型抗原拓展匹配适用范围中国专家共识[J].临床输血与检验, 2024,26(3):289-298.

[135]

LI X F, MA C Y, CAI X H, et al. Chinese expert consensus on red blood cell antigen extended matching range[J].J Clin Transfus Lab Med, 2024, 26(3):289-298.

[136]

江苏省预防医学会. 辐照血液使用指南: T/ JPMA 007-2020[S].南京:江苏省预防医学会, 2020:1-7.

[137]

Jiangsu Preventive Medicine Association. Guidelines for the use of irradiated blood: T/ JPMA 007-2020[S]. Nanjing: Jiangsu Preventive Medicine Association,2020:1-7.

[138]

薛瑞峰,赵崇希,王培宗,等. 输注陈旧红细胞对肝细胞癌切除术后病人预后的影响[J].中山大学学报 (医学科学版),2022,43(3):449-461.

[139]

XUE R F, ZHAO C X, WANG P Z, et al. Effect of prolonged storage of packed red blood cells on recurrence-free andoverall survivals after curative resection for hepatocellular carcinoma[J].J Sun Yat-sen Univ (Med Sci), 2022, 43(3):449-461.

[140]

刘桂芳,金勇,袁圆,等. 消化系统恶性肿瘤患者围手术期输注不同储存时间红细胞的效果分析[J].医学检验与临床,2024,35(11):17-20.

[141]

LIU G F, JIN Y, YUAN Y, et al. Effect analysis of perioperative transfusion of red blood cells with different storage times in patients with digestive system malignant tumors[J].Med Lab Sci Clin, 2024, 35(11):17-20.

[142]

KEKRE N, MALLICK R, ALLAN D, et al. The impact of prolonged storage of red blood cells on cancer survival[J].PLoS One,2013,8(7):e68820.

[143]

BENNETT-GUERRERO E, VELDMAN T H, DOCTOR A, et al. Evolution of adverse changes in stored RBCs[J].Proc Natl Acad Sci U S A,2007,104(43):17063-17068.

[144]

REYNOLDS J D, AHEARN G S, ANGELO M, et al. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood[J].Proc Natl Acad Sci U S A,2007,104(43):17058-17062.

[145]

ZALPURI S, ZWAGINGA J J, VAN DER BOM J G. Risk factors for alloimmunisation after red blood cell transfusions (R-FACT):a case cohort study[J].BMJ Open, 2012,2(3):e001150.

[146]

PANCH S R, MONTEMAYOR-GARCIA C, KLEIN H G. Hemolytic transfusion reactions[J].N Engl J Med, 2019,381(2):150-162.

[147]

WANG Y, RAO Q, LI X. Adverse transfusion reactions and what we can do[J].Expert Rev Hematol,2022,15 (8):711-726.

[148]

BOONPENG K, SHIBUTA T, HIROOKA Y, et al. Serum microRNAs as new biomarkers for detecting subclinical hemolysis in the nonacute phase of G6PD deficiency[J].Sci Rep,2024,14(1):16029-16038.

[149]

YIN Y, TIAN X, LI L, et al. First annual report of Chinese haemovigilance network[J].Vox Sang,2021,116 (6):718-724.

[150]

CANNATA A, CANTONI S, SCIORTINO A, et al. Mechanical hemolysis complicating transcatheter interventions for valvular heart disease:JACC state-of-the-art review[J].J Am Coll Cardiol,2021,77(18):2323-2334.

[151]

PEREK B, SLAWEK S, MALINSKA A, et al. Late subclinical hemolysis and long-term outcomes after aortic valve replacement with On-X mechanical prostheses -a preliminary single-center report[J].Kardiochir Torakochirurgia Pol,2017, 14(3):175-179.

[152]

BUNGER V, RUSS M, KUEBLER W M, et al. Predictive potential of ECMO blood flow for hemolysis and outcome of patients with severe ARDS[J].J Clin Med, 2024, 14(1):140-147.

[153]

FURST D, TSAMADOU C, NEUCHEL C, et al. Next-generation sequencing technologies in blood group typing[J].Transfus Med Hemother,2020,47(1):4-13.

[154]

AL-RIYAMI A Z, GAMMON R R, SEHEULT J, et al. Artificial intelligence and transfusion education, research and practice:The view from the ISBT Clinical Transfusion Working Party[J].Vox Sang,2026,121(4):481-487.

[155]

SEGHATCHIAN J. An introductory commentary on the use of artificial intelligence, machine learning and TQM, as novel computational tools in big data patterns or procedural analysis, in transfusion medicine[J].Transfus Apher Sci, 2020,59(6):102985.

AI Summary AI Mindmap
PDF (2993KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉